CLX - The Clorox Company
| Previous Close | 149.00 |
| Open | 151.04 |
| Bid | 147.57 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 151.04 - 154.51 |
| 52 Week Range | 113.57 - 154.51 |
| Volume | 1,410,069 |
| Avg. Volume | 1,039,293 |
| Market Cap | 19.482B |
| Beta (3Y Monthly) | 0.36 |
| PE Ratio (TTM) | 24.37 |
| EPS (TTM) | 6.26 |
| Earnings Date | Oct 31, 2018 |
| Forward Dividend & Yield | 3.84 (2.57%) |
| Ex-Dividend Date | 2018-10-30 |
| 1y Target Est | 137.07 |
- CNBC Videos•5 days ago
Cramer's No. 1 fear in this market? The rally in shares o...
Jim Cramer explains why a surge in a stock like Clorox can mean bad news for the broader economy.
- CNBC Videos•5 days ago
Cramer's No. 1 fear in this market
Jim Cramer explains why a surge in a stock like Clorox can mean bad news for the broader economy.
- Yahoo Finance Video•9 days ago
Global oil supply hits 100 barrels per day
Yahoo Finance's Seana Smith, Dion Rabouin, Jen Roger and Brian Sozzi discuss what's next for oil with Bubba Trading's Todd Horwitz.
Markit•22 hours agoSee what the IHS Markit Score report has to say about Clorox Co.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.
- American City Business Journals•2 days ago
Exclusive: Global investor KKR to buy Oakland landmark for $255 million
The 24-story office tower that houses Clorox's headquarters is selling for the third time in six years as Oakland's office market heats up.
- Investor's Business Daily•2 days ago
Stock Indexes Battle At 200-Day Lines, Try To Hold Off Bears
Among IBD's 197 stock groups, soap, personal care and oil stocks were the day's top performers as the indexes retook their 200-day moving averages.
- Zacks•2 days ago
Why Clorox (CLX) Could Beat Earnings Estimates Again
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Business Wire•2 days ago
Burt’s Bees Sensitive Skin Regimen Helps Support Skin Barrier Function, Promotes Visibly Healthy-looking Skin in Atopic Dermatitis/Eczema and Rosacea
Brand presents at inaugural Integrative Dermatology Symposium during Sacramento’s first Wellness Week
- PR Newswire•3 days ago
POP! Gourmet® Enters Partnership Agreement with the makers of Hidden Valley® Ranch to Bring America's Favorite Ranch to the Salty Snack Aisle
New popcorn and chips available in national retailers and online SEATTLE , Oct. 18, 2018 /PRNewswire/ -- POP! Gourmet , a leader in innovative snack food products, announced today the launch of Hidden ...
Market Realist•3 days agoAnalysts Have Neutral View on CL Stock ahead of Q3 Results
The majority of Wall Street analysts maintain a neutral outlook on Colgate-Palmolive (CL) stock. Analysts expect a heightened promotional environment and adverse currency rates to hurt the company’s top line, which they expect to decline in the third quarter. Meanwhile, soft sales and higher raw and packaging material costs are expected to hurt its margins in the near term. Also, the company’s EPS growth rate is expected to slow down significantly.
Markit•3 days agoSee what the IHS Markit Score report has to say about Clorox Co.
CLX credit default swap spreads are within the middle of their range for the last three years. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Market Realist•4 days agoWhy Colgate-Palmolive’s Sales Could Falter in the Third Quarter
Colgate-Palmolive (CL) is likely to disappoint investors with its top-line performance in the third quarter. Analysts expect Colgate-Palmolive to report net sales of $3.9 billion, down 1.7% on a YoY (year-over-year) basis.
Market Realist•4 days agoWhy Colgate-Palmolive’s Q3 Results May Not Impress Investors
Colgate-Palmolive (CL) is expected to announce its third-quarter results on Friday, October 26. However, analysts expect the company to disappoint investors with its third-quarter sales and earnings performance. Similar to Procter & Gamble (PG) and Kimberly-Clark (KMB), Wall Street expects Colgate-Palmolive’s top line also to see a YoY (year-over-year) decline.
- TheStreet.com•5 days ago
Clorox Is Giving Me Mixed Signals
has made a strong rally from 2013 (see the Point and Figure chart below) but the weekly bar chart shows a wide trading range market the past three years. In this daily bar chart of CLX, below, we can see that prices display an up and down pattern. The daily On-Balance-Volume (OBV) line shows a rise from May and suggests that CLX will move to new highs.
Market Realist•5 days agoKimberly-Clark: Analysts’ Recommendations and Target Price
A few Wall Street analysts downgraded Kimberly-Clark (KMB) stock before its third-quarter results. On October 10, Deutsche Bank downgraded Kimberly-Clark stock to “sell” from “hold” and lowered the target price to $99 from $108. On October 8, Goldman Sachs downgraded Kimberly-Clark stock to “neutral” from “buy” and reduced the target price by $1 to $119.
- CNBC•5 days ago
Cramer Remix: Investors should take a bite of this stock
CNBC's Jim Cramer breaks down why last week’s sell-off is making Yum Brands’ stock an attractive buy into weakness. The "Mad Money" host also hears from cannabis producer MedMen's co-founder and CEO, Adam Bierman. Marketwide stock declines may have investors questioning whether their stock picks are dropping for the right reasons, so on Monday, CNBC's Jim Cramer decided to pinpoint a winner on the decline: Yum Brands YUM .
- CNBC•5 days ago
Cramer's No. 1 fear in this market? The rally in shares of Clorox
CNBC's Jim Cramer explains why a surge in a stock like Clorox can mean bad news for the broader economy. The "Mad Money" host connects the move to the Fed's rate hike plans. As the stock market tried and failed to regain its bull status on Monday, with the tech sector driving the major averages lower into the close, what really worried CNBC's Jim Cramer were the stocks going up.
Market Realist•6 days agoKimberly-Clark’s Margins Could Continue to Slide
Kimberly-Clark’s (KMB) profit margins haven’t impressed investors in the past several quarters. The company continues to struggle on the margins front. Lower pricing, increased commodity and shipping costs, and soft volumes have taken a toll on the company’s profitability.
Market Realist•6 days agoAnalysts Expect Kimberly-Clark’s Top Line to Decline
Analysts expect Kimberly-Clark (KMB) to report total revenues of $4.5 billion in the third quarter—down 2.1% compared to the same period last year. Analysts expect soft volumes and weak pricing to continue to hurt the company’s organic sales growth rate and overall sales. Negative currency rates pose a threat to the top line in the third quarter.
Market Realist•6 days agoKimberly-Clark: Weak Q3 Results Could Weigh on the Stock
Kimberly-Clark (KMB) is scheduled to announce to its third-quarter results on October 22. However, analysts’ estimate for the third quarter reflects that the company will likely disappoint investors with its sales and earnings performance.
Market Realist•6 days agoIFF Opens Two New Facilities in China
On October 8, International Flavors and Fragrances (IFF) announced that it opened two new facilities in China. The first facility is a flavor manufacturing plant in the free trade zone of Zhangjiagang, which opened on October 9. The second facility is a natural product research lab located in the Nanjing Life Science Park, which will open on October 15.
Market Realist•9 days agoProcter & Gamble: Analysts’ Recommendations before Q1 2019
Wall Street analysts are maintaining a neutral outlook on Procter & Gamble (PG) stock. Of the 24 analysts tracking PG stock, 17 analysts recommend a “hold” rating, six analysts suggest a “buy,” and one analyst recommends a “sell.” Analysts have a consensus target price of $84.08 per share on PG stock, which indicates an upside of 3.2% based on its closing price of $81.44 on October 10.
Market Realist•9 days agoCL, CHD, and CLX’s Valuations Don’t Look Attractive Yet
As we discussed in Part 1, Colgate-Palmolive (CL), Church & Dwight (CHD), and Clorox (CLX) shares declined considerably in the past few days following Deutsche Bank’s negative stance. Despite the recent decline, the companies’ stocks aren’t attractive on the valuation front.
Market Realist•9 days agoAnalyzing the Weakness in KMB, PG, CL, CHD, and CLX
Shares of consumer packaged goods manufacturers in the United States have decline considerably in the past few days. Deutsche Bank turned negative on the prospects of the companies operating in the consumer packaged goods sector on October 10.
Market Realist•9 days agoWhat Analysts Forecast for P&G’s Bottom Line in Q1 2019
So far, Procter & Gamble (PG) has impressed with its bottom-line performance and has a strong track record of exceeding analysts’ expectations. Procter & Gamble has exceeded analysts’ earnings estimates in the last 13 consecutive quarters, with an average earnings surprise of 4.4%. This performance comes amid a weak sales and margins environment.
